Key points are not available for this paper at this time.
This comprehensive review evaluates the advancements, potential, and ethical implications of nanotechnology in medical diagnostics within the U.S. healthcare system. The primary objective was to assess how nano-tools are revolutionizing early disease detection and management. The methodology involved a systematic review of peer-reviewed literature, focusing on studies published between 2000 and 2023. Data sources included academic databases such as PubMed, Scopus, and Web of Science, supplemented by secondary sources like journals and conference proceedings. The study emphasized the historical development of nanotechnology in diagnostics, current innovations, and future prospects in the field. Key findings reveal significant advancements in nano-diagnostic tools, highlighting their increased sensitivity and specificity in early disease detection. Innovations such as nano-enabled imaging and targeted drug delivery systems have shown potential in personalizing patient care. However, the study also identified challenges, including ethical concerns related to patient privacy, data security, and the need for comprehensive regulatory frameworks. The review concludes that while nanotechnology in diagnostics offers transformative potential, it also presents unique challenges. Recommendations for industry leaders and policymakers include fostering innovation within ethical and safety boundaries, investing in research, and establishing clear regulatory guidelines. Future research directions emphasize long-term efficacy and safety studies, cost-effective manufacturing processes, and exploring new applications in disease management. This study underscores the pivotal role of nanotechnology in shaping the future of healthcare diagnostics.
Balogun et al. (Sun,) studied this question.